loading
前日終値:
$0.358
開ける:
$0.384
24時間の取引高:
9.89M
Relative Volume:
15.20
時価総額:
$39.26M
収益:
-
当期純損益:
$-37.65M
株価収益率:
-0.2008
EPS:
-1.67
ネットキャッシュフロー:
$-24.14M
1週間 パフォーマンス:
-52.26%
1か月 パフォーマンス:
-69.54%
6か月 パフォーマンス:
-81.39%
1年 パフォーマンス:
-73.82%
1日の値動き範囲:
Value
$0.315
$0.3857
1週間の範囲:
Value
$0.30
$0.8299
52週間の値動き範囲:
Value
$0.30
$4.28

Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Company Profile

Name
名前
Reviva Pharmaceuticals Holdings Inc
Name
セクター
Healthcare (1171)
Name
電話
(408) 501-8881
Name
住所
10080 N WOLFE ROAD, CUPERTINO
Name
職員
14
Name
Twitter
Name
次回の収益日
2025-03-31
Name
最新のSEC提出書
Name
RVPH's Discussions on Twitter

RVPH を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
RVPH
Reviva Pharmaceuticals Holdings Inc
0.3353 39.26M 0 -37.65M -24.14M -1.67
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
445.22 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
520.96 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
320.80 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
561.38 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
240.62 28.51B 3.81B -644.79M -669.77M -6.24

Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2023-09-20 開始されました ROTH MKM Buy
2023-06-08 開始されました The Benchmark Company Speculative Buy
2022-01-24 開始されました H.C. Wainwright Buy

Reviva Pharmaceuticals Holdings Inc (RVPH) 最新ニュース

pulisher
Jun 10, 2025

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) Given Consensus Rating of “Buy” by Brokerages - Defense World

Jun 10, 2025
pulisher
Jun 08, 2025

Ameriprise Financial Inc. Takes $84,000 Position in Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) - Defense World

Jun 08, 2025
pulisher
Jun 06, 2025

RVPH: Open Label Extension Results & Key Opinion Leader Discussion - MSN

Jun 06, 2025
pulisher
Jun 05, 2025

Reviva to Participate in the H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference - GlobeNewswire

Jun 05, 2025
pulisher
Jun 05, 2025

Late-Stage CNS Drug Developer Reviva Pharma Reveals New Pipeline Updates at Major Neuroscience Conference - Stock Titan

Jun 05, 2025
pulisher
Jun 04, 2025

Data Readout Positive from Trial of New Schizophrenia Drug - streetwisereports.com

Jun 04, 2025
pulisher
Jun 04, 2025

Reviva Pharmaceuticals (NASDAQ:RVPH) Receives Buy Rating from D. Boral Capital - Defense World

Jun 04, 2025
pulisher
Jun 03, 2025

Reviva Pharmaceuticals (RVPH) Receives Buy Rating from D. Boral - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Reviva reports positive year-long schizophrenia drug study By Investing.com - Investing.com South Africa

Jun 03, 2025
pulisher
Jun 02, 2025

Reviva Pharmaceuticals Holdings, Inc. Announces Positive Full Dataset for 1-Year Phase 3 Recover Open Label Extension Study Evaluating Brilaroxazine in Schizophrenia - MarketScreener

Jun 02, 2025
pulisher
Jun 02, 2025

Reviva Reports Positive Full Dataset For Phase 3 RECOVER OLE Study Of Brilaroxazine In Schizophrenia - Nasdaq

Jun 02, 2025
pulisher
Jun 02, 2025

Reviva reports positive year-long schizophrenia drug study - Investing.com Australia

Jun 02, 2025
pulisher
Jun 02, 2025

Reviva Pharmaceuticals (RVPH) Unveils Promising Phase 3 Brilaroxazine Study Results | RVPH Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Reviva Pharmaceuticals Completes Phase 3 Study for Schizophrenia - TipRanks

Jun 02, 2025
pulisher
Jun 02, 2025

Reviva Pharmaceuticals Reports Positive 1-Year Phase 3 Results for Brilaroxazine in Schizophrenia, Highlighting Efficacy and Safety - Nasdaq

Jun 02, 2025
pulisher
Jun 02, 2025

Reviva Announces Positive Full Dataset for 1-Year Phase 3 - GlobeNewswire

Jun 02, 2025
pulisher
Jun 02, 2025

Breakthrough in Schizophrenia Treatment: Phase 3 Trial Reveals Sustained Efficacy Over 12 Months - Stock Titan

Jun 02, 2025
pulisher
May 31, 2025

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) Shares Sold by Millennium Management LLC - Defense World

May 31, 2025
pulisher
May 30, 2025

Reviva Pharmaceuticals Launches $50M At-Market Offering - TipRanks

May 30, 2025
pulisher
May 30, 2025

Reviva Pharmaceuticals Holdings IncEnters Into At Market Issuance Sales AgreementSEC Filing - marketscreener.com

May 30, 2025
pulisher
May 26, 2025

What is Zacks Small Cap’s Estimate for RVPH Q2 Earnings? - Defense World

May 26, 2025
pulisher
May 23, 2025

Roth Capital Issues Positive Forecast for RVPH Earnings - Defense World

May 23, 2025
pulisher
May 22, 2025

D. Boral Capital Lowers Reviva Pharmaceuticals (NASDAQ:RVPH) Price Target to $3.00 - Defense World

May 22, 2025
pulisher
May 20, 2025

Reviva Pharmaceuticals Reports Q1 2025 Financial Results - TipRanks

May 20, 2025
pulisher
May 20, 2025

Reviva stock target cut to $3 on cash concerns, retains Buy rating - Investing.com Australia

May 20, 2025
pulisher
May 20, 2025

Spotify To Rally More Than 16%? Here Are 10 Top Analyst Forecasts For Tuesday - NewsBreak: Local News & Alerts

May 20, 2025
pulisher
May 20, 2025

Reviva to Participate in Upcoming Investor Conferences in May 2025 - GlobeNewswire

May 20, 2025
pulisher
May 20, 2025

Late-Stage CNS Drug Developer Reviva Opens Access to Management at Benchmark and Lytham Conferences - Stock Titan

May 20, 2025
pulisher
May 20, 2025

Reviva Pharmaceuticals (RVPH): Analyst Maintains Buy Rating, Low - GuruFocus

May 20, 2025
pulisher
May 20, 2025

Reviva Pharmaceuticals (RVPH) Sees Price Target Reduction Amid Funding Concerns | RVPH Stock News - GuruFocus

May 20, 2025
pulisher
May 20, 2025

Reviva Pharmaceuticals (RVPH): Analyst Maintains Buy Rating, Lowers Price Target | RVPH Stock News - GuruFocus

May 20, 2025
pulisher
May 16, 2025

Reviva Reports First Quarter 2025 Financial Results and Recent Business Highlights - The Manila Times

May 16, 2025
pulisher
May 16, 2025

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) Receives Consensus Rating of “Buy” from Brokerages - Defense World

May 16, 2025
pulisher
May 15, 2025

Reviva Pharmaceuticals (RVPH) Advances Brilaroxazine Program Tow - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Reviva Pharmaceuticals (RVPH) Advances Brilaroxazine Program Towards Approval | RVPH Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Major Milestone: 446 Patients Complete Reviva's Schizophrenia Drug Trial, Full Results Expected Q2 2025 - Stock Titan

May 15, 2025
pulisher
May 13, 2025

Reviva to Participate in the A.G.P. Healthcare Company Showcase - GlobeNewswire

May 13, 2025
pulisher
May 13, 2025

Tower Research Capital LLC TRC Has $48,000 Stock Holdings in Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) - Defense World

May 13, 2025
pulisher
May 11, 2025

Reviva Pharmaceuticals (RVPH) Expected to Announce Earnings on Tuesday - Defense World

May 11, 2025
pulisher
May 04, 2025

Short Interest in Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) Grows By 30.5% - Defense World

May 04, 2025
pulisher
May 03, 2025

Geode Capital Management LLC Grows Position in Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) - Defense World

May 03, 2025
pulisher
May 01, 2025

Schizophrenia Market to Witness Significant Growth by 2034 Across 7MM as New Therapies Enter Late-Stage Trials | DelveInsight - GlobeNewswire Inc.

May 01, 2025
pulisher
Apr 29, 2025

Reviva to Participate in the Citizens Life Sciences Conference - GlobeNewswire

Apr 29, 2025
pulisher
Apr 29, 2025

Reviva Pharma CEO Takes Center Stage: Key Updates Coming at Major Life Sciences Conference - Stock Titan

Apr 29, 2025
pulisher
Apr 28, 2025

Gaining Ground: Reviva Pharmaceuticals Holdings Inc (RVPH) Closes Lower at 0.86, Down -4.98 - DWinneX

Apr 28, 2025
pulisher
Apr 28, 2025

Market Update: American Rebel Holdings Inc (AREB) Sees Negative Movement, Closing at 3.85 - DWinneX

Apr 28, 2025
pulisher
Apr 27, 2025

Reviva Pharmaceuticals Holdings, Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report(R) - ACCESS Newswire

Apr 27, 2025
pulisher
Apr 26, 2025

D. Boral Capital Reiterates “Buy” Rating for Reviva Pharmaceuticals (NASDAQ:RVPH) - Defense World

Apr 26, 2025
pulisher
Apr 24, 2025

Reviva Pharmaceuticals Holdings Inc Inc. (RVPH) Price Performance: The Role of Supply and Demand - investchronicle.com

Apr 24, 2025
pulisher
Apr 24, 2025

Reviva to Present Late-Breaking Poster on the RECOVER - GlobeNewswire

Apr 24, 2025
pulisher
Apr 24, 2025

Major Phase 3 Breakthrough: Reviva Unveils 12-Month Schizophrenia Treatment Data at ASCP 2025 - Stock Titan

Apr 24, 2025

Reviva Pharmaceuticals Holdings Inc (RVPH) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$20.42
price down icon 1.37%
$35.45
price up icon 0.65%
$21.06
price down icon 1.92%
$101.83
price down icon 0.41%
$105.86
price down icon 0.39%
biotechnology ONC
$244.00
price down icon 3.69%
大文字化:     |  ボリューム (24 時間):